Purchase Order 75N94023P00776
- Not listed
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,182.40 firm fixed price delivery order is for gene synthesis services. Genscript specializes in providing customized DNA, antibodies, proteins, peptides, and other molecular biology products and services to support biomedical research and public health initiatives...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company, for plasmid cloning and propagation services. The $11,409.96 contract is for work to be performed in Piscataway, New Jersey. Genscript, which specializes in gene synthesis, gene editing, and other molecular biology services, has received numerous prime and...
This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of Agriculture (USDA). This contract does not have a set-aside designation. Genscript has a significant blanket purchase agreement (BPA) with USDA's Animal and Plant Health Inspection Service (APHIS), valued at up to $1.5 million through August 2024, to provide SARS-CoV-2 surrogate virus neutralization test kits and associated reagents in support of the agency's animal disease monitoring and research efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 8/25/23 |